Barclays analyst Alex Scott raised the firm’s price target on Ryan Specialty (RYAN) to $88 from $76 and keeps an Overweight rating on the shares. The firm updated organic growth assumptions for the insurance broker following Q3 earnings and the latest industry pricing data.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty Group Reports Robust Q3 2024 Performance
- Ryan Specialty in final talks to acquire Innovisk Capital
- Ryan Specialty maintains FY24 outlook for organic revenue growth at 13%-14%
- Ryan Specialty reports Q3 adjusted EPS 41c, consensus 42c
- Ryan Specialty price target raised to $84 from $75 at BofA